If we want to increase the chances of survival in various diseases today, such as cancer, heart disease and diabetes, therapeutic approaches should be tailored as precisely as possible to the individual patient. Personalized cell and gene therapies make this possible but are difficult to realize due to the expenses in supply chain management. The… Continue reading Whitepaper: Why is Supply Chain Orchestration in Cell & Gene Therapies so important?
Read the thoughts of our CEO Andreas Göbel and our Head of Business Development Dr. Camila Mendes on “Cell and Gene Therapy Orchestration: Real-Time Supply Chain Management” in the November issue of Cell & Gene Therapy Insights by BioInsights. In this article, they highlight the potential of cell and gene therapy orchestration software for personalized… Continue reading Future of Advanced and Personalized Therapies – Cell and Gene Therapy Insights Article
Starting a business is a thrilling and challenging endeavor that requires commitment, hard work, and perseverance. The journey from idea to start-up is often filled with twists and turns, successes and failures, and a lot of learning along the way. In an interview that has now appeared on the CAMELOT blog, you will explore Andreas’ journey… Continue reading Our Managing Director’s Journey: From Having an Idea to Founding a Start-Up
München (DE), Boston (US), March 8th, 2023 Hypertrust Patient Data Care (HPDC) today released a first beta version of its Hypertrust X-Chain Supply Chain Management solution for ATMP (Advanced Therapy Medicinal Products) to selected customers. Version 3.0 of the solution will be generally available in Q2 2023. The refreshed and extended version features a completely… Continue reading HPDC releases a New Version of The Hypertrust X-Chain with Intuitive UI
Munich (DE) – Personalized cell and gene therapies are emerging capabilities that are transforming patient care as we know it. In the following joint Whitepaper with Dell and CellPoint, you can learn more about Personalized Cell and Gene Therapy Orchestration and its implications on logistical processes. Personalized treatments, like autologous cell therapies, are based… Continue reading Whitepaper: Revolutionizing Cell & Gene Therapy Orchestration through the use of a Point-of-Care Manufacturing Model
When 07. March 2023 – 08. March 2023 Where Boston, MA What -> Event Website Munich (DE) / Boston (US) – The 4th Supply Chain & Logistics Summit is the established industry gathering that focuses on securing the entire cell and GTx supply chain. With our solution Hypertrust X-Chain we focus exactly on these challenges.… Continue reading Supply Chain & Logistics for Cell Therapies Summit: Tackling Today’s Supply Chain Challenges
Personalized cancer treatments are one of sciences’ hopes for fighting cancer effectively. But the promising treatments also impose a big challenge: The treatments’ orchestration is a complex task, a dimension that existing IT systems are barely capable to address by existing workflows in the supply chain and transport management of the companies and service providers… Continue reading Trustworthy Orchestration: Transgene Makes Its Clinical Trials Simple and Safe
Munich (DE) – Cell & gene therapies (CGT) is here to revolutionize modern healthcare offering unique opportunities to develop new therapeutic approaches to treat and potentially cure myriad diseases. But the end-to-end coordination of supply chain management for those type of therapies – personalized therapies – is hence complex and poses many challenges. To… Continue reading Orchestration for Cell & Gene Therapies in a Nutshell
La Hulpe (BXL) /Munich (DE) – September 2022 – Hypertrust Patient Data Care was part of the Bio Supply Chain Management Alliance (BSMA) annual European conference in Belgium and a fantastic surprise waited for our Managing Director Andreas Göbel. A great gala at the end of a great conference: Together with our partner Arvato… Continue reading HPDC Awarded with BSMA Europe Annual Conference Award 2022
Leiden (NL) / Munich (DE) – November 2021 – CellPoint and Hypertrust Patient Data Care (HPDC) today announced the launch of xCellit. The xCellit system was co-developed to make autologous cell therapies available more rapidly and efficiently by facilitating the scheduling, monitoring and data capturing of cell treatment workflows. It is based on HPDC’s X-Chain… Continue reading CellPoint and Hypertrust Patient Data Care co-develop xCellit platform for cell therapies at the point-of-care
© 2024 Hypertrust
